(2-hydroxy-6-(piperidin-2-yl)pyridin-4-yl)boronic acid is primarily used in organic synthesis and medicinal chemistry. It serves as a key intermediate in the development of pharmaceuticals, particularly in the synthesis of compounds targeting enzyme inhibition or receptor modulation. Its boronic acid group makes it valuable in Suzuki-Miyaura cross-coupling reactions, which are widely employed to construct complex organic molecules, including drug candidates. Additionally, its structural features, such as the pyridine and piperidine moieties, contribute to its potential in designing molecules with enhanced bioavailability and binding affinity for biological targets. This compound is also explored in the development of boron-containing drugs, which are gaining attention for their therapeutic applications in areas like cancer treatment and infectious diseases.